The drug, called dexamethasone, is a common steroid that is typically used to treat conditions including arthritis, eczema and asthma. (Image: Yoav Levy)The clinical trial gave 2,100 Covid-19 patients a low dose of dexamethasone, while a further 4,300 patients were given standard NHS care. Leading scientists running the RECOVERY trial say the £6 drug will now become the standard of care for all Covid-19 patients on oxygen in hospitals. By comparison 13% of hospitalised Covid-19 patients died in the 28 day period. “That’s a major, major step forward.

Source: Daily Mirror June 16, 2020 13:20 UTC